AstraZeneca reported $2.63 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 2.66 2.38 Nov/05
FY2026Q2 Jun/2026 2.63 2.50 2.17 Jul/27
FY2026Q1 Mar/2026 2.58 2.5 2.49 Apr/29
FY2025Q4 Dec/2025 2.12 2.13 2.09 Feb/10
FY2025Q3 Sep/2025 2.38 2.3 2.08 Nov/06




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Alcon AG USD 0.85 0.07 Mar/2026
Almirall EUR 0.07 0.03 Dec/2025
Amgen USD 6.29 1.14 Jun/2026
argenx SE USD 6.44 1.74 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Autolus Therapeutics Ltd USD -0.27 0.07 Mar/2026
Bayer EUR 0.95 1.76 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Fresenius EUR 0.82 0.04 Mar/2026
Fresenius Medical Care EUR 1.12 0.21 Jun/2026
Genmab DKK 3.69 2.77 Dec/2025
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
GRIFOLS EUR 0.23 0.09 Jun/2026
Haleon GBP 0.04 0.01 Jun/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.84 12.73 Mar/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.11 0.23 Mar/2026
Merck USD -0.13 1.15 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Orion EUR 1 0.34 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Philips EUR 0.49 0.26 Jun/2026
Recordati EUR 0.65 0.08 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
UCB EUR 5.65 3.21 Dec/2025